Amundi
BBIO icon

Amundi’s BridgeBio Pharma BBIO Stock Holding History

Amundi’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$927K Sell
12,446
-164
-1% -$11.5K ﹤0.01% 1404
2026
Q1 		$936K Buy
12,610
+7,954
+171% +$577K ﹤0.01% 1310
2025
Q4 		$356K Buy
+4,656
New +$306K ﹤0.01% 1601
2022
Q4 		– Sell
-13,866
Closed -$157K – 1903
2022
Q3 		$157K Hold
13,866
– – ﹤0.01% 1484
2022
Q2 		$131K Buy
13,866
+8,453
+156% +$70.7K ﹤0.01% 1410
2022
Q1 		$62K Hold
5,413
– – ﹤0.01% 1518
2021
Q4 		$70K Hold
5,413
– – ﹤0.01% 1596
2021
Q3 		$254K Hold
5,413
– – ﹤0.01% 1412
2021
Q2 		$330K Buy
+5,413
New +$309K ﹤0.01% 1310

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Amundi's BBIO Position: Q2 2026 in Review

Amundi reduced its BridgeBio Pharma (BBIO) stake by 1.3% in Q2 2026, selling an estimated $11.5K and leaving 12,446 shares worth $927K. The position accounts for ﹤0.01% of the portfolio, ranked #1404.

Amundi first reported a position in BBIO in Q2 2021 and has held it in 9 quarters since. The position peaked at $936K in Q1 2026. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Amundi held 12,446 shares of BridgeBio Pharma worth $927K as of Q2 2026.
  • Amundi sold 164 BridgeBio Pharma shares in Q2 2026, an estimated $11.5K.
  • BridgeBio Pharma made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1404 holding.
  • Amundi first reported a position in BridgeBio Pharma in Q2 2021 and has held it in 9 quarters since.
  • Amundi's BridgeBio Pharma position peaked at $936K in Q1 2026.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.